24 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 24 of 24 clinical reviews.
A source-audited look at the 5-HTP and Dayvigo (lemborexant) interaction: what is established, what is pharmacologically plausible, and what a prescriber or pharmacist still needs to verify before you combine them.
A clinical review of the pharmacokinetic and pharmacodynamic interactions between alpha-lipoic acid and lemborexant (Dayvigo), with dosing guidance, monitoring parameters, and safety considerations.
A guide to the pharmacokinetic and pharmacodynamic interactions between ashwagandha (Withania somnifera) and lemborexant (Dayvigo), with dosing guidance, monitoring advice, and when to call your prescriber.
A board-reviewed clinical guide to the berberine, lemborexant interaction: CYP3A4 pharmacokinetics, blood-sugar overlap, dosing strategy, and when to call your prescriber.
Learn whether calcium supplements interact with Dayvigo (lemborexant), including pharmacokinetic data, dose-separation guidance, and monitoring recommendations from clinical evidence.
A guide to the CoQ10 and Dayvigo (lemborexant) interaction, covering pharmacokinetics, pharmacodynamics, dosing, monitoring, and safety.
A clinical review of creatine and Dayvigo (lemborexant) co-use: pharmacokinetic interactions, creatinine elevation concerns, renal monitoring guidance, and practical dosing advice prepared by the HealthRX.com Editorial Team.
A clinical review of the ginseng, lemborexant interaction: pharmacokinetics, CYP3A4 effects, glucose impact, anticoagulant risk, and what your prescriber needs to know before you combine them.
Evidence-based guide on combining glycine supplements with Dayvigo (lemborexant) for insomnia. Covers pharmacodynamic interactions, dose timing, monitoring, and clinical recommendations.
What is established, what is plausible, and what remains unverified about combining L-theanine with lemborexant (Dayvigo) for sleep, based on the FDA label and general pharmacology.
A guide covering the pharmacokinetic and pharmacodynamic interaction between lion's mane mushroom and lemborexant (Dayvigo), including dosing considerations, monitoring parameters, and safety guidance.
A board-reviewed guide to combining magnesium supplements with Dayvigo (lemborexant). Covers pharmacokinetic and pharmacodynamic interactions, safe dosing windows, monitoring, and when to call your prescriber.
Learn whether melatonin is safe to combine with Dayvigo (lemborexant), including interaction mechanisms, dose-separation strategies, and monitoring guidance from clinical evidence.
A guide to the pharmacokinetic and pharmacodynamic interaction between NAC and lemborexant (Dayvigo), with dosing guidance, monitoring tips, and when to call your prescriber.
A guide to the omega-3 and lemborexant interaction: pharmacokinetics, antiplatelet pharmacodynamics, bleeding risk, triglyceride monitoring, and practical dosing advice.
Quercetin may inhibit CYP3A4, the enzyme that metabolizes Dayvigo. Learn about the pharmacokinetic interaction, dose-separation strategies, and monitoring guidance.
A guide to the resveratrol, lemborexant interaction: CYP3A4 pharmacokinetics, estrogenic effects, practical dosing guidance, and monitoring advice for patients taking Dayvigo.
Evidence-based guide on combining saw palmetto supplements with Dayvigo (lemborexant) for insomnia. Covers drug-supplement interactions, CYP3A4 metabolism, monitoring, and clinical recommendations.
St. John's Wort is a potent CYP3A4 inducer that significantly reduces lemborexant (Dayvigo) blood levels, making the sleep medication less effective. Learn the mechanism, the clinical risk, and what to do if you are already taking both.
Evidence-based guide on combining turmeric or curcumin supplements with Dayvigo (lemborexant) for insomnia, including CYP3A4 interaction risk, dose-separation strategy, and monitoring advice.
Evidence-based guide on combining vitamin B12 supplements with Dayvigo (lemborexant) for insomnia. Covers drug interactions, safety data, dosing windows, and monitoring recommendations.
A clinical review of the vitamin B6 and Dayvigo (lemborexant) interaction, covering pharmacokinetics, dose safety, neuropathy risk at high doses, and when to call your prescriber.
A guide on combining vitamin D with Dayvigo (lemborexant). Learn the pharmacokinetics, interaction risk, monitoring parameters, and safe dosing practices.
A guide covering the pharmacokinetic and pharmacodynamic considerations of combining zinc supplements with Dayvigo (lemborexant), including dosing, monitoring, and safety guidance.